<div id="readability-page-1"><div><p><span>Aeon Biopharma Inc </span><span>:</span></p><ul><li>AEON BIOPHARMA ANNOUNCES FIRST CLOSING OF PIPE INVESTMENT AND PROVIDES UPDATE ON FDA TYPE 2A MEETING SCHEDULING</li><li>AEON BIOPHARMA INC: FDA BPD TYPE 2A MEETING NOW SCHEDULED FOR JANUARY 21, 2026</li><li>AEON BIOPHARMA INC - FIRST CLOSING OF PIPE RESULTS IN $1.79 MILLION PROCEEDS</li></ul></div></div>

AEON

<p>Aeon Biopharma Inc :AEON BIOPHARMA ANNOUNCES FIRST CLOSING OF PIPE INVESTMENT AND PROVIDES UPDATE ON FDA TYPE 2A MEETING SCHEDULINGAEON BIOPHARMA INC: FDA BPD TYPE 2A MEETING NOW SCHEDULED FOR JANUARY 21, 2026AEON BIOPHARMA INC - FIRST CLOSING OF PIPE RESULTS IN $1.79 MILLION PROCEEDS</p>

Aeon Biopharma Announces First Closing Of Pipe Investment And Provides Update On FDA Type 2A Meeting Scheduling